NEW YORK (GenomeWeb News) – Affymetrix this week said it sold its Anatrace business to investment firm StoneCalibre for an undisclosed amount. Anatrace is based in Maumee, Ohio and is a highly specialized developer, manufacturer, and distributor of high-purity detergents and synthetic lipids used in membrane protein research. An Affymetrix spokesman said Anatrace's revenues were not material to the company's overall financials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."